Peutz-Jeghers syndrome screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
Screening for cancerous lesions by small intestine radiography, [[esophagogastroduodenoscopy]] (EGD), [[colonoscopy]], pancreatic [[ultrasound]], [[pelvic ultrasound]], [[mammography]], and Papanicolaou (Pap) test are recommended among patients with Peutz-Jeghers syndrome.  
Screening for cancerous lesions by small intestine radiography, [[esophagogastroduodenoscopy]] (EGD), [[colonoscopy]], pancreatic [[ultrasound]], [[pelvic ultrasound]], [[mammography]], and Papanicolaou test ([[Pap test]]) are recommended among patients with Peutz-Jeghers syndrome.
 
==Screening==
==Screening==
Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the [[hamartomas]] by:
Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the [[hamartomas]] by:

Revision as of 20:23, 16 September 2015

Peutz-Jeghers syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Peutz-Jeghers syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Peutz-Jeghers syndrome screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Peutz-Jeghers syndrome screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Peutz-Jeghers syndrome screening

CDC on Peutz-Jeghers syndrome screening

Peutz-Jeghers syndrome screening in the news

Blogs on Peutz-Jeghers syndrome screening

Directions to Hospitals Treating Peutz-Jeghers syndrome

Risk calculators and risk factors for Peutz-Jeghers syndrome screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Screening for cancerous lesions by small intestine radiography, esophagogastroduodenoscopy (EGD), colonoscopy, pancreatic ultrasound, pelvic ultrasound, mammography, and Papanicolaou test (Pap test) are recommended among patients with Peutz-Jeghers syndrome.

Screening

Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the hamartomas by:

Screening for cancerous lesions among patients with Peutz-Jeghers syndrome include the following:[1]

References

  1. Boardman LA, Thibodeau SN, Schaid DJ; et al. (1998). "Increased risk for cancer in patients with the Peutz-Jeghers syndrome". Ann. Intern. Med. 128 (11): 896–9. PMID 9634427.

Template:Digestive system neoplasia


Template:WH Template:WS